Copegus (ribavirin)

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC, Hoffmann-La Roche

Conditions

Hepatitis C, Chronic

Phase 3

Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471)

CompletedNCT00081770

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2004-03-31End: 2007-11-30Updated: 2017-04-04

Phase 4

A Study of Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis C

CompletedNCT00940420

Hoffmann-La RocheHepatitis C, Chronic

Start: 2002-10-31End: 2009-11-30Updated: 2016-11-02

Related Papers

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.

2009-07-22833 citations